Delivery Order SPE2DB20D3101-SPE2DB25FRVV9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,517.23 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhaler (12 grams) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,438.62 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,766.80 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the...
- The Defense Logistics Agency awarded a delivery order valued at $13,747.80 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,255.74 to AmerisourceBergen Drug Corp for Advair HFA 45-21 mcg inhalers (12 gm units) on September 8, 2025, with completion scheduled for September 9, 2025. This competitive award, issued under a firm fixed-price structure with no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,889.48 to AmerisourceBergen Drug Corp for Advair HFA 45-21 mcg inhalers (12 grams) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania headquarters. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $11,601.36 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) under a firm fixed price contract, with an ultimate completion date of September 3, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $5,105.61 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12-gram units) with an ultimate completion date of August 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,207.05 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, issued on August 7, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVV9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,260.90 to AmerisourceBergen Drug Corp for Advair HFA 45-21 mcg inhalers (12 grams) with an ultimate completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling the company to supply medications and medical supplies to support military healthcare systems worldwide. AmerisourceBergen's extensive federal contract portfolio with the DLA demonstrates its critical role as a pharmaceutical distributor for the Defense Health Agency and other federal healthcare entities, with delivery orders spanning a broad range of therapeutic medications from specialty drugs to generic pharmaceuticals, vaccines, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| No Federal Contract Transactions match your search | ||||